Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 587
Appendix A
Statement of Task
In a two-phased process, an ad hoc committee will undertake the second phase to conduct
the assessment/evaluation of HIV/AIDS programs implemented under the Tom Lantos and
Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria
Reauthorization Act of 2008 and issue a report to the U.S. Congress on the committee's findings
and recommendations in 2012. In conducting the evaluation, the committee will follow the
approach developed in the first phase, described in the IOM/NRC report, Strategic Approach to
the Evaluation of Programs Implemented Under the Tom Lantos and Henry J. Hyde U.S. Global
Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
The congressionally-mandated tasks are an assessment of the performance of United
States-assisted global HIV/AIDS programs and an evaluation of the impact on health of
prevention, treatment, and care efforts that are supported by United States funding, including
multilateral and bilateral programs involving joint operations. 1
Further, Congress asked that the IOM study include the following as part of its
evaluation:
(i) an assessment of progress toward prevention, treatment, and care targets;
(ii) an assessment of the effects on health systems, including on the financing and
management of health systems and the quality of service delivery and staffing;
(iii) an assessment of efforts to address gender-specific aspects of HIV/AIDS, including
gender-related constraints to accessing services and addressing underlying social and
economic vulnerabilities of women and men;
(iv) an evaluation of the impact of treatment and care programs on 5-year survival rates,
drug adherence, and the emergence of drug resistance;
(v) an evaluation of the impact of prevention programs on HIV incidence in relevant
population groups;
(vi) an evaluation of the impact on child health and welfare of interventions authorized
under the Act on behalf of orphans and vulnerable children;
(vii) an evaluation of the impact of programs and activities authorized in the Act on child
mortality; and
(viii) recommendations for improving the HIV/AIDS programs implemented under the
US Global Leadership against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act
of 2008.
Sponsor: U.S. Department of State
1
Note: “Joint operations” has been interpreted as per instruction from Senate Foreign Relations and OGAC
headquarters staff as limiting multilateral program evaluations to only those in which the multilateral programs are
actually jointly executed with bilateral programs; other multilateral programs will be excluded.
PREPUBLICATION COPY: UNCORRECTED PROOFS
A-1
OCR for page 588
